Ngày 11/06/1988 | 09:40.

Prytime Medical has announced the closing of a US$6 million inside financing round to support commercialisation of its resuscitative endovascular balloon occlusion of the aorta (REBOA)haemorrhage control products.

Ngày 10/06/1988 | 10:17.

Royal Philips recently announced positive two-year results from the TOBA (Tack optimised balloon angioplasty) II below-the-knee (BTK) clinical trial.

Ngày 09/06/1988 | 02:37.

Cardiovascular Systems has announced that the full line of OrbusNeich Jade percutaneous transluminal angioplasty (PTA) over-the-wire (OTW) balloon catheters is now available in the USA. Cardiovascular Systems is the exclusive US distributor of OrbusNeich balloon products.

Ngày 08/06/1988 | 09:08.

Simulators have long been used for training surgeons and surgical teams, but traditional simulator platforms typically have a built-in limitation: they often simulate one or a limited number of conditions that require performance of isolated tasks, such as placing an intravenous catheter, instead of simulating and providing opportunities for feedback on the performance of multiple interventions that a trauma victim may require at the same time. To overcome this limitation, the Advanced Modular Manikin (AMM), an innovative simulation platform that allows integration of other simulation devices, was developed and field testing was conducted, with support from the Department of Defense (DoD).

Ngày 08/03/1988 | 10:51.

The first detailed surgical results from the UK National Health Service (NHS) Abdominal Aortic Aneurysm Screening Programme (NAAASP) show that, over a seven-year period, the turn down rate after referral for treatment with a screen-detected AAA and perioperative mortality were low. However, the data also reveal that there remains “considerable” variation between local screening programmes in the proportion undergoing endovascular repair. These findings were published in the February edition of the European Journal of Vascular and Endovascular Surgery (EJVES).

Ngày 28/02/1988 | 09:45.

Inovise Medical has announced that the US Food and Drug Administration (FDA) has granted breakthrough device designation for its Audicor heart failure management system. The system uses clinically-tested algorithms to detect the risk of decompensation at home in patients who have been previously hospitalized for heart failure.

Ngày 26/02/1988 | 01:52.

Access Vascular has announced US Food and Drug Administration (FDA) clearance of its HydroMID midline catheter.

Ngày 12/01/1988 | 09:26.

According to the AMBUVASC randomised controlled trial (RCT), outpatient hospitalisation is not cost-effective compared with inpatient hospitalisation for endovascular repair of patients with claudication at a €50,000/quality-adjusted life year (QALY) threshold. Yann Gouëffic (Groupement Hôpitalier Paris St Joseph, Paris, France) and colleagues caution against generalisation of their conclusion. “The findings depend on the specific organisation in France,” they state, “where the two procedures are performed within the same institution”.

Ngày 11/01/1989 | 11:38.

Exercise can play an important role in treating peripheral arterial disease(PAD), a recent review from Amy Harwood (Centre for Sport and Exercise Life Sciences, Coventry University, Coventry, and the Faculty of Health Sciences, University of Hull, Hull, UK) et al, published in the British Medical Journal (BMJ) Open Sport and Exercise Medicine, shows. The review concluded that, for people with PAD, exercise programmes may help improve walking ability and quality of life by relieving symptoms of leg pain, cramps, and fatigue.

Ngày 05/01/1988 | 10:06.

Writing for Cardiovascular News, Harold Dauerman, Rony Lahoud and Newton Phuong from the University of Vermont Larner College of Medicine, Burlington, USA reflect on the implications of the POPular TAVI trial and how it is shaping approaches to antiplatelet therapy after TAVI.

Ngày 26/11/2020 | 08:41.

Penumbra today announced US Food and Drug Administration (FDA) 510(k) clearance for expanded indication of the latest iteration of the Indigo aspiration system, Lightning 12.

Ngày 05/10/2020 | 09:19.

Teleflex has announced it has received 510(k) clearance from the US Food and Drug Administration to expand the indications for use of the Arrow EZ-IO intraosseous vascular access system. This device can be used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases.

CUSTOMER REVIEWS

  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search
Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389

TOP